To further investigate the potential role of the USP37–BLM axis as a target for cancer therapy, we knocked down USP37 or BLM individually or together in MCF7 cells or MDA-MB-231 cells with high USP37 level (Figure 7B), and examined the cell survival following cisplatin or IR treatment. This evidence concerns the gene USP37 and cancer.